Sakurai et al. utilized cRGD-LNPs to remodel the extracellular matrix (ECMs) in the tumor microenvironment by delivering vascular endothelial growth factor receptor 2 (VEGFR2) siRNA (Sakurai et al.2016). Here, KDR is linked to neoplasm.